(Q44042850)

29 November 2017

title

VAD regimen in the treatment of resistant multiple myeloma: slow or fast infusion? (English)

1 reference

29 November 2017

Koskela K

1

1 reference

29 November 2017

Pelliniemi TT

series ordinal

2

1 reference

29 November 2017

Remes K

series ordinal

3

1 reference

29 November 2017

publication date

1 July 1993

1 reference

29 November 2017

1 reference

29 November 2017

volume

10

1 reference

29 November 2017

issue

4-5

1 reference

29 November 2017

page(s)

347-351

1 reference

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148559

Therapy of primary resistant and relapsed multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148559

VAD chemotherapy for refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148559

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148559

VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148559

10.3109/10428199309148559

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference